SetPoint Medical is a pioneering bioelectronic medicine company that offers patients and providers a safe and cost-effective approach for the treatment of chronic autoimmune disease. SetPoint Medical recently closed $64 mm preferred stock financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis. This financing was led by New Enterprise Associates (NEA).